Search research articles
Contact Us
Filters
Showing results (131-140 of 157) with videos related to
Page
of 16
Sort By:
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
November 1, 2016
Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost-effectiveness Analysis
Michael J Twiner, Alexander L Marinica, Kenneth Kuper, et al.
American Journal of Hypertension
|
August 25, 2022
Does Vitamin D Provide Added Benefit to Antihypertensive Therapy in Reducing Left Ventricular Hypertrophy Determined by Cardiac Magnetic Resonance?
Phillip D Levy, Michael J Twiner, Aaron M Brody, et al.
Ethnicity & Disease
|
November 25, 2003
For the patient. What is the Metabolic Syndrome and why is it important?
W Dallas Hall, Luther T Clark, Nanette K Wenger, et al.
Ethnicity & Disease
|
November 25, 2003
The Metabolic Syndrome in African Americans: a review
W Dallas Hall, Luther T Clark, Nanette K Wenger, et al.
Lancet (London, England)
|
March 7, 2026
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial
Michel Azizi, Jenifer M Brown, Jamie P Dwyer, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
August 24, 2025
Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24
John M Flack, Michel Azizi, Jenifer M Brown, et al.
Disease Management : DM
|
February 10, 2006
The metabolic syndrome: recognition and management
W Dallas Hall, Laurence O Watkins, Jackson T Wright, et al.
Kidney Medicine
|
December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials
John M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Hypertension (Dallas, Tex. : 1979)
|
December 30, 2015
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study
George Thomas, Dawei Xie, Hsiang-Yu Chen, et al.
The New England Journal of Medicine
|
April 23, 2025
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
Luke J Laffin, Branko Kopjar, Carrie Melgaard, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 157) with videos related to
Sort By:
Page
of 16
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
November 1, 2016
Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost-effectiveness Analysis
Michael J Twiner, Alexander L Marinica, Kenneth Kuper, et al.
American Journal of Hypertension
|
August 25, 2022
Does Vitamin D Provide Added Benefit to Antihypertensive Therapy in Reducing Left Ventricular Hypertrophy Determined by Cardiac Magnetic Resonance?
Phillip D Levy, Michael J Twiner, Aaron M Brody, et al.
Ethnicity & Disease
|
November 25, 2003
For the patient. What is the Metabolic Syndrome and why is it important?
W Dallas Hall, Luther T Clark, Nanette K Wenger, et al.
Ethnicity & Disease
|
November 25, 2003
The Metabolic Syndrome in African Americans: a review
W Dallas Hall, Luther T Clark, Nanette K Wenger, et al.
Lancet (London, England)
|
March 7, 2026
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial
Michel Azizi, Jenifer M Brown, Jamie P Dwyer, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
August 24, 2025
Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24
John M Flack, Michel Azizi, Jenifer M Brown, et al.
Disease Management : DM
|
February 10, 2006
The metabolic syndrome: recognition and management
W Dallas Hall, Laurence O Watkins, Jackson T Wright, et al.
Kidney Medicine
|
December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials
John M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Hypertension (Dallas, Tex. : 1979)
|
December 30, 2015
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study
George Thomas, Dawei Xie, Hsiang-Yu Chen, et al.
The New England Journal of Medicine
|
April 23, 2025
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
Luke J Laffin, Branko Kopjar, Carrie Melgaard, et al.
Page
of 16